GSK plc (GSK)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $101.13B
Last updated: Nov 17, 2026 at 11:06 AM ET
GSK plc (GSK) Government Contracts
Federal agencies obligated $21.03M to GSK over the 12 months through Jul 31, 2026, down 25.4% from the prior 12 months. That is less than 1% of its revenue. Department of Health and Human Services was the top awarding agency with 95.8% of obligations across 4 agencies.
Federal Obligations
Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.
- Obligations
- $21.03M
- Change
- -25.4%
- Obligations to revenue
- 0.1%
| Prior 12 months | $28.18M |
|---|---|
| Contracts with activity | 27 |
| New contracts | 9 |
| Top agency | Department of Health and Human Services |
| Top agency share | 95.8% |
|---|---|
| Agencies | 4 |
| Average remaining term | 9.2 months |
12 months through Jul 31, 2026
Largest New Awards
The 9 largest new awards total $19.59M, and the largest makes up 92.9% of that.
| Award ID | Agency | Amount | Start | End | Description |
|---|---|---|---|---|---|
| 75A50325C00019 | Department of Health and Human Services, Office of Assistant Secretary for Preparedness and Response | $18.20M | Sep 30, 2025 | Sep 29, 2027 | RELENZA (ZANAMIVIR) ROTADISK, 5MG |
| 19AQMM25F1490 | Department of State, Department of State | $667,575 | Sep 9, 2025 | Oct 9, 2025 | 2025 - 2026 FLU VACCINES |
| 75A50126F61020 | Department of Health and Human Services, Office of Assistant Secretary for Preparedness and Response | $493,470 | Mar 13, 2026 | Oct 29, 2026 | TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN |
| 15F06726F0000234 | Department of Justice, Federal Bureau of Investigation | $105,000 | Feb 27, 2026 | Dec 31, 2026 | GSK VACCINES |
| W901UZ25FA029 | Department of Defense, Department of the Army | $32,603 | Aug 21, 2025 | Sep 13, 2025 | 210 BOXES FLUARIX TRIVALENT, INFLUENZA VACCINE,TRIVALENT (PF),SYRINGE,0.5ML |
| 19PCRD26K1496 | Department of State, Department of State | $24,928 | Dec 8, 2025 | Jan 2, 2026 | MEDICAL SUPPLIES |
| 19PCRD26K1497 | Department of State, Department of State | $24,928 | Dec 8, 2025 | Jan 2, 2026 | MEDICAL SUPPLIES |
| 19PCRD26K1498 | Department of State, Department of State | $24,928 | Dec 8, 2025 | Jan 2, 2026 | MEDICAL SUPPLIES |
| W912L726FA017 | Department of Defense, Department of the Army | $15,076 | Apr 23, 2026 | May 23, 2026 | HEPATITIS A AND B VACCINES FOR TENNESSEE ARMY NATIONAL GUARD. |
Monthly Obligations
The latest complete month, Apr 2026, had net de-obligations of $6,764. The largest month in the table was Sep 2024, at $9.47M, the last month of the federal fiscal year.
| Month | Obligations |
|---|---|
| Jul 2026 | -$0 |
| Jun 2026 | $8.46M |
| May 2026 | $714,478 |
| Apr 2026 | -$6,764 |
| Mar 2026 | $3.21M |
| Feb 2026 | -$138,813 |
| Jan 2026 | $0 |
| Dec 2025 | -$41,084 |
| Nov 2025 | $16,212 |
| Oct 2025 | $0 |
| Sep 2025 | $8.27M |
| Aug 2025 | $548,581 |
| Month | Obligations |
|---|---|
| Jul 2025 | -$28,216 |
| Jun 2025 | $9.35M |
| May 2025 | $2.17M |
| Apr 2025 | $9.45M |
| Mar 2025 | $882 |
| Feb 2025 | $182,305 |
| Jan 2025 | -$4.23M |
| Dec 2024 | $4,898 |
| Nov 2024 | -$19,679 |
| Oct 2024 | $0 |
| Sep 2024 | $9.47M |
| Aug 2024 | $1.84M |
Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.
Frequently Asked Questions About GSK
How much does GSK receive in federal contracts?
GSK had $21.03M in federal contract obligations over the 12 months through Jul 31, 2026, compared with $28.18M in the 12 months before, down 25.4%. Obligations are contract bookings by the awarding agency, not recognized revenue.
What are GSK's largest government contracts?
The largest new awards over the 12 months through Jul 31, 2026 were 75A50325C00019, Department of Health and Human Services, $18.20M, started Sep 30, 2025; 19AQMM25F1490, Department of State, $667,575, started Sep 9, 2025; 75A50126F61020, Department of Health and Human Services, $493,470, started Mar 13, 2026.
Which agencies award GSK contracts?
Department of Health and Human Services was the top awarding agency with 95.8% of obligations over the 12 months through Jul 31, 2026. The records cover 4 agencies. Other agencies in the awards list include Department of State, Department of Justice, Department of Defense.
What new federal contracts did GSK win in the 12 months through Jul 31, 2026?
GSK won 9 new federal contracts in the 12 months through Jul 31, 2026. The largest was 75A50325C00019, Department of Health and Human Services, $18.20M, started Sep 30, 2025.
How do GSK's federal obligations compare with its revenue?
Federal contract obligations were $21.03M over the 12 months through Jul 31, 2026, equivalent to less than 1% of GSK's revenue. Obligations are amounts the government committed to contracts in the period, not the share of GSK's revenue that comes from the government.
GSK pages: Overview, Dividends, Financials, Valuation, Competitors, Government Contracts